Ballinger Susan
Indiana University School of Medicine, Indianapolis 46202, USA.
Curr Opin Rheumatol. 2003 Sep;15(5):591-4. doi: 10.1097/00002281-200309000-00012.
The purpose of this review is to educate the reader about the one of the most common vasculitides of childhood: Henoch-Schonlein purpura. Although the disease has been described for over a century, the etiology has yet to be discovered. Adult-onset Henoch-Schonlein purpura is unusual, but through case studies, this review examines some of the common manifestations of this presentation of disease. Long-term outcome studies are still defining how this disease affects a small but significant percentage of patients afflicted with Henoch-Schonlein purpura.
This article will summarize recent work in molecular biology and genetics evaluating predisposing factors in the development of Henoch-Schonlein purpura. Further illustrations of the various complications of Henoch-Schonlein purpura will be reviewed. Recent long-term studies of outcomes of patients with renal disease from Henoch-Schonlein purpura will be summarized.
After reading this review, the clinician will be able to elucidate the manifestations of Henoch-Schonlein purpura, determine appropriate treatment of the disease, and, most importantly, give the patient information about long-term consequences of Henoch-Schonlein purpura.
本综述旨在让读者了解儿童最常见的血管炎之一:过敏性紫癜。尽管该病已被描述了一个多世纪,但其病因尚未明确。成人过敏性紫癜并不常见,但通过病例研究,本综述探讨了这种疾病表现的一些常见症状。长期预后研究仍在确定这种疾病如何影响一小部分但数量可观的过敏性紫癜患者。
本文将总结分子生物学和遗传学方面最近的研究工作,评估过敏性紫癜发病的易感因素。还将回顾过敏性紫癜各种并发症的更多实例。将总结最近对过敏性紫癜肾病患者预后的长期研究。
阅读本综述后,临床医生将能够阐明过敏性紫癜的症状,确定该疾病的适当治疗方法,最重要的是,向患者提供有关过敏性紫癜长期后果的信息。